Cancer in dogs: the common types, the signs, and honest answers about what treatment can do

Cancer is the most common cause of death in dogs over ten. The most-cited UK figures, drawn from a Royal Veterinary College study of half a million dogs in primary care, put the lifetime cancer incidence in the rough order of one in three across all breeds and significantly higher in some. By the time you are reading this you may already have heard the word in a consulting room, or you may be trying to understand what a lump or a recent change might mean.

This article is an honest introduction. It explains the cancers most commonly diagnosed in dogs in UK practice, how each tends to behave, what treatment options realistically achieve, what they cost in time and money and tolerance, and how to think about the conversations that follow a diagnosis. Reviewed by an RCVS-qualified veterinary surgeon. For specific cancers you want to read more about, we link out to dedicated articles where they exist.

What "cancer" means in a dog

Cancer is not one disease. It is the name for any condition in which a particular group of cells in the body has lost the normal controls on its own growth. Some cancers are slow and local: they sit, they grow, they make a nuisance of themselves but they don't travel. Others are fast and aggressive, with a strong tendency to spread to other organs (metastasise) and a much shorter clinical course.

The single most important thing to understand is that the word "cancer" covers a vast range. A grade I mast cell tumour on the leg that is fully removed at surgery is, statistically, a one-time event the dog never thinks about again. A high-grade splenic haemangiosarcoma is, in many cases, a six-week conversation. The diagnosis matters; the type matters far more.

This is also why a first reaction of "we'll fight it" or "we'll just let nature take its course" is rarely the right reaction. Both might be the right answer for a given cancer in a given dog. Almost as often, neither is. The right answer usually sits somewhere in between, shaped by what the cancer actually is, what the dog is like, and what your family can carry.

Because of this, it is understandable that many families wish to avoid invasive procedures unless absolutely necessary. However, identifying the exact type of cancer is often crucial, and this frequently requires a needle aspirate or biopsy. Obtaining this information allows us to provide a more accurate prognosis and recommend the most appropriate treatment options.

The most common types in UK practice

Although there are many different forms of cancer, a relatively small number are seen regularly in general veterinary practice. Here, we introduce some of the most common types and explain their key features.

Lymphoma is one of the most common cancers in dogs, often presenting as enlarged lymph nodes someone notices when fussing the neck or under the jaw. It is also one of the most chemotherapy-responsive cancers in veterinary medicine. Untreated, multi-centric lymphoma usually progresses over weeks to a couple of months. With a modern chemotherapy protocol (most commonly CHOP), median survival is around twelve months, with many dogs in remission and feeling well for most of that time. Prednisolone alone, much cheaper and tolerated by almost every dog, typically gives one to three months. Treatment refusal is a respectable choice for many families; chemotherapy in dogs is gentler than in people, but it is still a commitment, and the cancer almost always comes back eventually.

Osteosarcoma is the classic large-breed bone cancer, most commonly affecting Greyhounds, Rottweilers, Great Danes, and other giant breeds. It usually presents as a sudden lameness that fails to settle. By the time it is diagnosed, microscopic spread to the lungs has almost always already happened. The hard conversation is regarding amputation: removing the limb removes a profoundly painful tumour and improves quality of life remarkably well, but in itself doesn't address the disease that has already spread. With amputation plus chemotherapy, median survival is around twelve months; with amputation alone, around four to six. Many families choose palliative pain management instead, which can give weeks to a couple of months of comfortable time before the metastatic lung disease becomes unmanageable.

Mast cell tumours are common skin lumps, very variable in behaviour. A low-grade mast cell tumour completely removed with clean margins is often a one-time event with excellent prognosis. A high-grade mast cell tumour, particularly in certain locations or with evidence of spread, is a much more serious illness with a survival often measured in months. Grade is the single most important piece of information after diagnosis, and is obtained from biopsy, not from how the lump looks on the dog.

Haemangiosarcoma is an aggressive cancer and, unfortunately, often carries a poor prognosis. Many dogs are diagnosed after a splenic tumour ruptures, causing sudden internal bleeding. While surgery to remove the spleen can stabilise the immediate situation, the cancer has often already spread elsewhere in the body. Even with surgery and chemotherapy, median survival is typically around six months, while surgery alone generally results in survival times of only a few months. German Shepherd Dogs, Golden Retrievers and Labrador Retrievers are affected more commonly than many other breeds.

Soft tissue sarcomas are a broad family of tumours of connective tissue. Most are locally invasive (they extend further than they look) but slow to spread. Wide surgical excision is usually the central treatment, with radiotherapy or further surgery if margins are incomplete. Prognosis varies enormously by grade and location.

Mammary tumours are most common in unspayed or late-spayed female dogs. Roughly half are benign. Of those that are malignant, surgical removal early is often curative; left late, they spread to lungs and other sites. Early spaying significantly reduces lifetime risk.

Oral tumours, particularly squamous cell carcinoma and melanoma, present as masses in the mouth, bad breath, blood-tinged saliva, or reluctance to eat. Many are aggressive locally and some spread early. Treatment usually involves surgery, sometimes radical, sometimes followed by radiotherapy.

This is not an exhaustive list. Brain tumours, urinary tract cancers, pancreatic and liver cancers all occur.

The honest treatment conversation

Most vets, talking honestly, would describe the canine cancer conversation in three brackets.

The first bracket is curative intent. The cancer is one where surgery, sometimes plus radiotherapy or chemotherapy, has a realistic chance of resolving the disease for the rest of the dog's natural life. This includes most benign tumours, completely-excised low-grade mast cell tumours, many low-grade soft tissue sarcomas, and some early-caught mammary tumours.

The second bracket is disease control with good quality of life. The cancer is not curable, but treatment can buy meaningful time with a reasonable quality of life. Chemotherapy for lymphoma is the textbook example. Amputation plus chemotherapy for osteosarcoma is another. Many soft tissue sarcoma cases sit here. Treatment can be effective, but involves expense, repeat visits and the possibility of side effects.

The third bracket is comfort and dignity, without trying to slow the disease. This is sometimes framed as "doing nothing", which it isn't. Good palliative care for a dog with advanced cancer is active, attentive, and skilled. Pain control, anti-nausea medication, appetite support, nutritional adjustment, environmental change, attention to wound care or bleeding tumours, and frank conversations about when to step in. For many families, particularly with very advanced disease or older dogs with concurrent conditions, this is the kindest choice from diagnosis. For others, it is the right choice eventually after a period of more active treatment.

Treatment refusal is not failure. A dog who has had thirteen good years and gets to spend the last few weeks of life eating roast chicken on the sofa, comfortably medicated, with the people they love around them, has been served well by their families. So has a dog who has had a year of remission on CHOP and then a peaceful goodbye. Both are reasonable paths to take and the dog's quality of life is what matters.

What it costs

Cost is one of the things most people find hardest to ask about and often regret not asking about. Rough pricing as an approximation for 2026 is as follows.

Initial work-up (consultation, imaging, biopsy, pathology) usually sits in the high hundreds to low thousands. A specialist oncology referral consultation alone is several hundred. A typical CHOP chemotherapy protocol for lymphoma runs across about six months and totals roughly £4,000 to £7,000 depending on practice and complications. Amputation surgery alone is typically £2,000 to £4,000. Adjunctive chemotherapy after amputation pushes total cost into the £5,000 to £9,000 range. Radiotherapy is delivered at a handful of UK centres and tends to be £4,000 to £8,000 for a course.

Pet insurance can make a substantial difference to what treatment is affordable, depending on the level and type of cover. It is important to check the details of individual policies, particularly any limits on per-condition or annual payouts, as these can significantly affect what is reimbursed.

Where insurance is not in place, treatment plans are necessarily shaped by both medical appropriateness and financial constraints. Vets will always aim to recommend what is clinically appropriate, and will discuss options openly so that decisions can be made in a way that is realistic for each individual situation.

Palliative care is usually much less. Medication for a dog on comfort-only treatment for advanced cancer often comes to under £100 a month, sometimes far less.

Thinking about quality of life through a cancer diagnosis

Most cancers in dogs don't take their quality of life immediately. A dog newly diagnosed with lymphoma often feels well for weeks, and longer if treatment is started. A dog with an early mast cell tumour you have just had biopsied may have years ahead of them.

Quality of life becomes the question when the cancer (or its treatment) starts to affect what the dog can do and how the dog feels. Reduced appetite that doesn't respond to anti-nausea medication. Increasing pain that isn't managed by current analgesia. Visible weight and muscle loss. Tumours that bleed, smell, or become infected and can't be managed comfortably. A change in the dog you can see in their face and posture.

Our Quality of Life Assessment is a structured short tool to help think it through. The aim is not to give you a number that decides. The aim is to give shape to what you are already noticing.

When a cancer diagnosis does turn towards end-of-life care, home is often the kinder setting. Many dogs with advanced disease are exhausted by car journeys; many are most themselves on a familiar blanket in a familiar room. Our home euthanasia service is built for exactly this, and the line is open seven days a week if you would like to talk it through, with no obligation either way.

A short note for the family with a recent diagnosis

The first week after a serious cancer diagnosis is often the hardest. You are processing what you have just been told, looking for second opinions, reading conflicting things online, and trying to make decisions while feeling shaken. A few things that tend to help.

Ask your vet to write down the specifics: the exact cancer type, the grade if known, the stage, and the realistic options. Notes are easier to think over than memory.

Take a few days before deciding anything irreversible. Aside from very acute situations, almost no cancer decision needs to be made in twenty-four hours.

Talk to one other person whose judgement you trust. Often the most useful person is not another vet but someone who knew your dog before any of this started.

Look honestly at what your dog is like right now, not at what they were like a year ago. The decision is about the dog in front of you.

If specialist referral makes sense, ask for it. Most UK regions have access to a veterinary oncology service.

If it doesn't, or you decide it isn't right for your situation, that is not giving up. That is making the choice that fits your dog and your family.

References worth reading

• O'Neill DG et al. Longevity and mortality of owned dogs in England, The Veterinary Journal, 2013.
• Dobson JM et al. Prevalence of canine cancer in a UK population from the VetCompass programme, JSAP, 2014.
• BSAVA Manual of Canine and Feline Oncology, 4th edition.
• Withrow & MacEwen's Small Animal Clinical Oncology, 6th edition.
• Vail DM et al. Response of canine lymphoma to combination chemotherapy, JVIM, multiple papers.
• Selmic LE et al. Survival outcomes in dogs with appendicular osteosarcoma treated with limb amputation and chemotherapy, JAVMA, 2014.